{"id":"https://openalex.org/W4394533763","doi":"https://doi.org/10.6084/m9.figshare.19548547","title":"Supplementary Material for: Dynamic observation: Immune-privileged microenvironment limited the effectiveness of immunotherapy in an intraocular metastasis mouse model","display_name":"Supplementary Material for: Dynamic observation: Immune-privileged microenvironment limited the effectiveness of immunotherapy in an intraocular metastasis mouse model","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4394533763","doi":"https://doi.org/10.6084/m9.figshare.19548547"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/19548547","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Dynamic_observation_Immune-privileged_microenvironment_limited_the_effectiveness_of_immunotherapy_in_an_intraocular_metastasis_mouse_model/19548547","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"volume":null,"type":"supplementary-materials","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Dynamic_observation_Immune-privileged_microenvironment_limited_the_effectiveness_of_immunotherapy_in_an_intraocular_metastasis_mouse_model/19548547","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"T., Tao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T., Tao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Y., Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y., Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101535591","display_name":"Jiwang Zhang","orcid":"https://orcid.org/0000-0003-4309-2892","observed_orcids":["https://orcid.org/0000-0003-4309-2892"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J., Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067362159","display_name":"Lei Huang","orcid":"https://orcid.org/0000-0003-3881-5902","observed_orcids":["https://orcid.org/0000-0003-3881-5902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L., Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Y., Tao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y., Tao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.12020000070333481,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intraocular-metastasis","display_name":"intraocular metastasis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.5239999890327454},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.968999981880188},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8389999866485596},{"id":"https://openalex.org/keywords/cd8-tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating CD8+ T cells","score":0.9229999780654907},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.640999972820282},{"id":"https://openalex.org/keywords/fas-ligand","display_name":"Fas ligand","score":0.6209999918937683},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.7960000038146973},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7419999837875366},{"id":"https://openalex.org/keywords/intratumoral-hemorrhage","display_name":"intratumoral hemorrhage","score":0.7730000019073486},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7242797017097473},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6076713800430298},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5380456447601318},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.45316022634506226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3842982053756714},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3827372193336487},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34747421741485596},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34374433755874634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12836924195289612},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1087668240070343}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/19548547","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Dynamic_observation_Immune-privileged_microenvironment_limited_the_effectiveness_of_immunotherapy_in_an_intraocular_metastasis_mouse_model/19548547","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.19548547","doi":"https://doi.org/10.6084/m9.figshare.19548547","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.19548547","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.19548547.v1","doi":"https://doi.org/10.6084/m9.figshare.19548547.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.19548547.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/19548547","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Dynamic_observation_Immune-privileged_microenvironment_limited_the_effectiveness_of_immunotherapy_in_an_intraocular_metastasis_mouse_model/19548547","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4307869277","https://openalex.org/W2357948923","https://openalex.org/W4211132779","https://openalex.org/W4313472242","https://openalex.org/W4200022043","https://openalex.org/W2112727616","https://openalex.org/W2884525857","https://openalex.org/W4322720888","https://openalex.org/W4296613612","https://openalex.org/W3193904228"],"abstract_inverted_index":{"Introduction:":[0],"Intraocular":[1],"metastasis":[2,42,127,134],"(IM)":[3],"occurred":[4],"in":[5,73,103,137,204,231,251],"approximately":[6],"8-10%":[7],"of":[8,40,46,83,193,242,273,279,287],"patients":[9],"with":[10,115,190],"metastatic":[11],"malignancy,":[12],"for":[13,24,66],"whom":[14],"oncological":[15],"immunotherapies":[16],"showed":[17],"poor":[18],"visual":[19,294],"potential.":[20,295],"However,":[21],"the":[22,70,80,104,108,119,155,222,232,252,270,277,288,293],"mechanism":[23],"that":[25,175],"inefficiency":[26,167],"remains":[27],"unclear":[28],"and":[29,56,63,68,91,123,132,146,216,237],"requires":[30],"further":[31],"exploration.":[32],"Methods:":[33],"we":[34,78,209],"established":[35],"a":[36,211,239],"novel":[37],"mouse":[38],"model":[39],"intraocular":[41,126,133,152,274],"by":[43,88,95],"intracarotid":[44],"injection":[45],"cutaneous":[47],"melanoma":[48],"cells.":[49,265],"We":[50,59],"investigated":[51],"disease":[52,271],"progression":[53,272],"using":[54],"ophthalmic":[55],"histological":[57],"examinations.":[58],"used":[60],"combined":[61],"anti-PD-1":[62],"anti-CTLA4":[64],"antibodies":[65],"immunotherapy":[67],"evaluate":[69],"therapeutic":[71],"effects":[72,278],"mice":[74,100],"model.":[75],"In":[76],"addition,":[77],"characterized":[79],"immune":[81],"microenvironment":[82],"tumor":[84,188],"infiltrating":[85,221,263],"CD8+":[86,177,194,199,218,228,248,281],"T":[87,178,195,200,219,229,249,264,282],"fluorescence":[89],"staining":[90],"assessed":[92],"their":[93],"cytotoxicity":[94,243],"flow":[96],"cytometry.":[97],"Results:":[98],"All":[99],"presented":[101],"IM":[102,233,262],"left":[105],"eye,":[106],"while":[107],"right":[109],"eye":[110,158],"was":[111],"healthy.":[112],"Uveal":[113],"tissues":[114,173],"rich":[116],"vascularity":[117],"(e.g.,":[118],"iris,":[120],"ciliary":[121],"body,":[122],"choroid)":[124],"initiated":[125],"at":[128],"an":[129],"early":[130],"stage,":[131],"development":[135],"resulted":[136],"several":[138],"secondary":[139],"changes,":[140],"including":[141],"corneal":[142,185],"swelling,":[143],"retinal":[144],"detachment,":[145],"intratumoral":[147,223],"haemorrhage.":[148],"Immunotherapy":[149,267],"could":[150],"inhibit":[151,260,269],"metastasis,":[153],"prolong":[154],"time":[156],"to":[157,171,291],"rupture":[159,164],"but":[160],"did":[161],"not":[162,235],"prevent":[163],"ending.":[165],"This":[166],"might":[168],"be":[169,285],"attributed":[170],"ocular":[172,256],"specificities":[174],"inhibited":[176],"cells":[179,196,201,220,230,250,283],"infiltration":[180],"via":[181],"PD-L1":[182],"expression.":[183],"PD-L1low":[184],"tissue":[186,257],"resisted":[187],"invasion":[189],"high":[191],"levels":[192],"infiltration,":[197],"whereas":[198],"were":[202,234],"deficient":[203],"PD-L1high":[205],"uveal":[206],"metastasis.":[207,275],"Furthermore,":[208],"found":[210],"significantly":[212],"increased":[213],"PD-1+/-":[214,217],"CD4+":[215],"haemorrhage":[224],"area.":[225],"Although":[226],"these":[227,261],"exhausted":[236],"had":[238],"higher":[240],"capacity":[241],"(higher":[244],"Interferon-\u03b3":[245],"ratio)":[246],"than":[247],"blood,":[253],"FasL+":[254],"PD-L1+":[255],"can":[258,268],"strongly":[259],"Conclusions:":[266],"Enhancing":[276],"tumor-infiltrating":[280],"should":[284],"one":[286],"highest":[289],"potentials":[290],"improve":[292]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}